Discover 1,428 paid clinical trials in Clearwater, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,428
Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Tampa FL, Houston TX, Fairfax VA, Pittsburgh PA,
Sponsor: Pyxis Oncology, Inc
Sex: All
Age: 18+
Code: NCT06795412
Phase1, Phase2, Recruiting
Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis
for
Breast Cancer
Location: Tampa FL, Hilo HI, Honolulu HI
Sponsor: University of Hawaii
Sex: Female
Age: 20 - 70+
Code: NCT05369546
Recruiting
Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
for
Colorectal Cancer Screening, Hepatitis C Virus
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 45 - 70+
Code: NCT06745895
Recruiting
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
for
Brain Tumor, Non Small Cell Lung Cancer
Location: Tampa FL, Fort Lauderdale FL, Miami FL,
Sponsor: InSightec
Sex: All
Age: 18 - 70+
Code: NCT05317858
Phase3, Recruiting
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
for
Melanoma
Location: Tampa FL, Jacksonville FL, Tamarac FL, Athens GA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06246916
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
for
Non-small Cell Lung Cancer
Location: Tampa FL, Clermont FL, Orange City FL, Stuart FL,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06712316
Phase2, Phase3, Recruiting
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
for
Metastatic Non-small Cell Lung Cancer
Location: Tampa FL, Nashville TN, Houston TX, Baltimore MD,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT04410796
Phase2, Recruiting
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
for
Relapsed/Refractory Acute Myeloid Leukemia (AML),
Location: Tampa FL, Miami FL, Atlanta GA, Birmingham AL,
Sponsor: Cullinan Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT05143996
Phase1, Recruiting
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
Location: Tampa FL, Miami FL, Nashville TN, Houston TX,
Sponsor: BlossomHill Therapeutics
Sex: All
Age: 18+
Code: NCT06501196
Phase1, Recruiting
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
for
Small Cell Lung Carcinoma, Neuroendocrine Neoplasms,
Location: Tampa FL, Jacksonville FL, Miami FL, Mobile AL,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT05882058
Phase2, Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
for
Carcinoma, Squamous Cell
Location: Tampa FL, Orlando FL, Jacksonville FL, Atlanta GA,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Sex: All
Age: 60+
Code: NCT04892173
Phase3, Recruiting
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
for
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma,
Location: Tampa FL, Lakeland FL, Nashville TN, Memphis TN,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06324357
Phase1, Phase2, Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for
Melanoma, Cutaneous Malignant
Location: Tampa FL, Jacksonville FL, Miami FL, Chapel Hill NC,
Sponsor: Immatics US, Inc.
Sex: All
Age: 18+
Code: NCT06743126
Phase3, Recruiting
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma